药物分析学报（英文）2024，Vol.14Issue(9)：1267-1281,15.DOI:10.1016/j.jpha.2024.100979
Targeting NTCP for liver disease treatment:A promising strategy
Targeting NTCP for liver disease treatment:A promising strategy
Xin Tan 1Yu Xiang 2Jianyou Shi 1Lu Chen 3Dongke Yu1
作者信息
- 1. Department of Pharmacy,Sichuan Provincial People's Hospital,School of Medicine,University of Electronic Science and Technology of China,Chengdu,610072,China||Personalized Drug Therapy Key Laboratory of Sichuan Province,School of Medicine,University of Electronic Science and Technology of China,Chengdu,610072,China
- 2. College of Medicine,University of Electronic Science and Technology,Chengdu,610072,China
- 3. Department of Pharmacy,Sichuan Provincial People's Hospital,School of Medicine,University of Electronic Science and Technology of China,Chengdu,610072,China||Personalized Drug Therapy Key Laboratory of Sichuan Province,School of Medicine,University of Electronic Science and Technology of China,Chengdu,610072,China||Guanghan People's Hospital,Guanghan,Sichuan,618300,China
- 折叠
摘要
关键词
NTCP/Bile acids metabolism/NTCP inhibitor/Viral hepatitisKey words
NTCP/Bile acids metabolism/NTCP inhibitor/Viral hepatitis引用本文复制引用
Xin Tan,Yu Xiang,Jianyou Shi,Lu Chen,Dongke Yu..Targeting NTCP for liver disease treatment:A promising strategy[J].药物分析学报（英文）,2024,14(9):1267-1281,15.基金项目
The study was funded by Research Project of Sichuan Provincial Health Commission,China(Grant No.:21PJ071). （Grant No.:21PJ071）
